StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
INDOBORAX.NS$343.30-0.26%
Fair $343.30+0.0%

INDOBORAX.NS

Indo Borax & Chemicals Limited

Basic Materials / ChemicalsNSE

$343.30

-0.90 (-0.26%)

Fairly Valued+0.0%Fair Value $343.30Fund rank 31/100 · Data gapFallback financials|
SA 54/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $649.5M · quality 54.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: yahooPeriods: 5Warnings: 0yahoo: 5
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · INDOBORAX.NSLocal privado en este navegador · Indo Borax & Chemicals Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$11.0B

P/E

21.9x

↑

EV/EBITDA

15.6x

↑

ROE

13.0%

↑

Gross Margin

47.3%

↑

Debt/Equity

0.00

↓
52-Week Range$343
$178$354

TradingView lightweight chart

INDOBORAX.NS price, volumen y niveles de valoración

Último $343.30Periodo +132.1%
Fair value: $343.30

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2026 · 4 años de histórico normalizado

Revenue CAGR

+5.2%

FCF CAGR

+66.0%

FCF margin

40.3%

FCF / Net income

1.73x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.15B · net income $502.7M · FCF $868.6M

2022-FY → 2026-FY

Gross margin

47.3%-6.1% pts

Operating margin

19.0%-7.6% pts

Net margin

23.3%+2.6% pts

FCF margin

40.3%+33.8% pts
MetricTTM
2026
2025
2024
2023
2022
Income Statement
Revenue$2.15B$2.15B$1.75B$1.91B$2.25B$1.76B
Net Income$502.7M$502.7M$425.1M$389.8M$506.9M$363.7M
EBITDA$697.4M$697.4M$614.8M$545.2M$706.0M$510.3M
EPS——13.2512.1515.8011.33
Gross Margin47.3%47.3%53.3%46.5%49.5%53.4%
Operating Margin19.0%19.0%24.7%21.2%26.9%26.7%
Net Margin23.3%23.3%24.3%20.4%22.5%20.7%
Balance Sheet
Debt/Equity0.000.000.000.000.000.00
Current Ratio20.8520.85————
Cash Flow
Free Cash Flow$868.6M$868.6M$-1.11B$649.5M$552.8M$114.4M
Returns
ROE13.0%13.0%12.7%13.3%19.9%17.6%
Valuation
P/E21.9221.9213.2014.966.9214.15
EV/EBITDA15.6215.628.498.473.779.38
P/B2.852.851.671.991.382.48
Growth & Yield
Revenue Growth22.9%22.9%-8.4%-15.0%——
EPS Growth——9.1%-23.1%——
Dividend Yield0.3%0.3%————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +89.8%

Total return

+89.8%

Start / end P/E

n/dx → n/dx

EPS bridge

13.25 → n/d

Residual

+89.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.3%
Residual / FX / buybacks / cross-term+89.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.